Paul Geyer

Paul Geyer has over 25 years of experience in the pharmaceutical and biotech industries. Paul is currently the Director at Sonic Incytes, a position they have held for the past two years. Prior to this, they were with Sonic Incytes Medical Corp., TIMIA Capital, Claris Healthcare Inc., Starling Minds, Stoko, Eupraxia Pharmaceuticals, Discovery Parks and Nimbus Synergies, and TargetTape Inc. Paul has also served on the board of Neovasc Inc.

Paul Geyer's educational career includes a certificate program in venture capital from UC Berkeley Extension, a certified director program from UCLA Anderson School of Management, a diploma in strategic plan development from The University of British Columbia, a summer program in cardiovascular pathophysiology for engineers and scientists from the Massachusetts Institute of Technology, a B.A.Sc in electrical and biomedical engineering from The University of British Columbia, an accredited mentor program in entrepreneurship/entrepreneurial studies from the BC Innovation Council, and a year 1 CFA - Level 1 Program from the Institute of Chartered Financial Analysts. Paul also has a Canadian Securities Course from the Canadian Securities Institute.